Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Operationalizing Precision Medicine in Rare Disease Trials Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research Optimizing CRO and Vendor Selection - Examples from the Field
Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Operationalizing Precision Medicine in Rare Disease Trials Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research Optimizing CRO and Vendor Selection - Examples from the Field
